drugset / Trial / NCT00835874

Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis

NCT00835874 ↗

Terminated 57 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.

Timeline

Start
2007-06
Primary completion
2009-07
Completion
2009-07

Outcome

Missed primary endpoint

Stopped (Enrollment): “Difficulty in recruitment. Mothers of infants preferred to take probiotics bought over-the-counter over the possibility of being in a placebo group”

paper The overall incidence of Bell stage II to III NEC was 12%, with an incidence of 4% in the infants of the probiotic group and 18.2% in the placebo group (p = 0.12), respectively. PMID 23934538 ↗

paper Sepsis and mortality rates were similar. PMID 23934538 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacteria lactis Other / unclassified — Oral
Subject Lactobacillus acidophilus Other / unclassified — Oral